MEMORANDUM OF UNDERSTANDING BETWEEN THE FOOD AND DRUG ADMINISTRATION ANDJanuary 27th, 2009
FiledJanuary 27th, 2009This Memorandum of Understanding (MOU) negotiated pursuant to Article 3 of the Food and Drug Administration (FDA)/National Treasury Employees Union (NTEU) Collective Bargaining Agreement (CBA), is entered into for the purpose of facilitating a smooth, professional transition to the FDA’s new location in White Oak, Maryland and is applicable only to implementation of Phase 2 of the consolidation of FDA at White Oak (Center for Drug Evaluation and Research [CDER] Office Building). This MOU does not preclude negotiations, pursuant to the requirements of law and the provisions of the CBA, on any topics or issues that may arise in connection with subsequent phases of the consolidation or with other management-initiated changes occurring during the FDA’s occupancy of the White Oak facility. FDA shall appropriately notify NTEU, pursuant to the CBA in effect at the time, of all subsequent changes that trigger an obligation to bargain.